BSX FY 2024 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$16.7B+17.6% YoY

Gross Profit

$10.3B61.3% margin

Operating Income

$2.6B15.7% margin

Net Income

$1.9B11.1% margin

EPS (Diluted)

$1.25

Cash Flow

Operating Cash Flow

$3.4B

Free Cash Flow

$2.6B

Stock-Based Comp.

$266M

Balance Sheet

Total Assets

$39.4B

Total Liabilities

$17.4B

Stockholders' Equity

$21.8B

Cash & Equivalents

$414M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16.7B	$14.2B	+17.6%
Gross Profit	$10.3B	$8.8B	+16.3%
Operating Income	$2.6B	$2.2B	+20.8%
Net Income	$1.9B	$1.6B	+16.4%